Scienture Holdings Inc SCNX

$3.01 -0.03 (-0.99%)

Valuation

Market cap
5,364,000
Revenue TTM
$430,000
Net income TTM
$-41,510,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-9,653.49%
Debt to equity
0.15

Trading

Volume
7,200
Avg volume
193,531
Day's range
$2.93 – $3.15
Shares out
1,765,000
Stochastic %K
15%
Beta
3.57
Analysts
Moderate Buy
Price target
$6.00

Price

Company profile

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients w...

Show more

Scienture Holdings, Inc. operates as pharmaceutical company that focuses on development and commercialization of products for the treatment of central nervous system and cardiovascular diseases in the United States. The company develops SCN-102, an oral liquid formulation of losartan potassium that is in phase 1 for the treatment of hypertension, diabetic nephropathy, and reduction of the risk of stroke in patients with hypertension and left ventricular hypertrophy; and SCN-104, a multi-dose dihydroergotamine mesylate (DHE) injection pen. It also develops SCN-106, which is a thrombolytic agent that binds to fibrin in clots and converts entrapped plasminogen to plasmin; and SCN-107, a long-acting injection suspension formulation of a non-opioid analgesic for postsurgical local and regional analgesia. Scienture Holdings, Inc. is headquartered in Commack, New York.

Industry
Pharmaceutical Retailers
Sector
Healthcare
Phone
631 670 6039
Website
https://scienture.com
Address
20 Austin Boulevard, Commack, United States

Latest news

Stocktwits

MisterRagnirLothbrok Nov 12, 9:12 PM
Made some decent money this month so far. 💯 Check em out below, they called some bangers ahead of the runs Tap in below , best FREE group of bulls i know 🔥 $CTM.X $SCNX Xx
0 replies
Diverstj981 Nov 12, 3:07 PM
$SCNX the lack of communication and transparency from these Indian pieces of shxt regarding their earnings announcements is infuriating.
1 replies
BEATWALLSTREET Nov 11, 12:08 PM
$SCNX They’ll most likely report terrible earnings and tank the stock, wiping out shareholders in the process. Normally, you see one or two red flags with these scam stocks: questionable/ Indian management, Streeterville, or Maxim Group. This one has all three. That's a massive red flag.
0 replies
Skimman Nov 10, 4:25 PM
$VJET $VIVK $SCNX $GUTS $CMND SHUT UP. ITS TRASH a U KNOW IT
0 replies
Diverstj981 Nov 10, 11:07 AM
$SCNX Zack's has earnings scheduled for November 11th. TradingView November 12th. Anyone know which it is? Why are these clowns SO opposed to actual transparency and communication?
1 replies
BEATWALLSTREET Nov 9, 4:01 PM
$SCNX this trash will sink at least 30% on earnings
0 replies
MisterRagnirLothbrok Nov 5, 1:43 PM
Ticker SCAG had huge news, could go parabolic: Scage Future Enters into Strategic Cooperation Agreement with China Huaye Group SCAG has only 1.3 million shares float - Chinese - Watch it 👀🚀 $OMH $BFLY $CTM.X $SCNX ##
0 replies
Diverstj981 Nov 5, 3:15 AM
$SCNX A worthwhile read. We are definitely walking a kinfe's edge. https://simplywall.st/community/narratives/us/healthcare/nasdaq-scnx/scienture-holdings/x1pqht2n-late-stage-pipeline-and-commercial-platform-will-drive-long-term-value-potential?utm_source=Braze&utm_medium=email&utm_campaign=CommunityDigest
1 replies